Synthesis, characterization and in vitro antibacterial activity of new steroidal 5-en-3-oxazolo and thiazoloquinoxaline

European Journal of Medicinal Chemistry

Volumn 43, Issue 9, 2008, Pages 2040-2044

  Khan, Salman A ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Antibacterial activity; Oxazoloquinoxaline; Semicarbazone

Indexed keywords

AMOXICILLIN; CHOLEST 5 EN 3 OXAZOLE DERIVATIVE; DIMETHYL SULFOXIDE; OXAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE; STEROID; THIAZOLOQUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DISK DIFFUSION; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTERIA; CHOLESTENES; OXAZOLONE; QUINOXALINES;

EID: 50949092419     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.12.008     Document Type: Article

References (28)

1. Avilffe A.G. Clin. Infect. Dis. 24 (1997) 874
2. Datta D.V., Singh S.A., and Chhutani P.N. Am. J. Trop. Med. Hyg. 23 (1974) 586-589
3. Alauddin M., and Smith M.M. J. Pharm. Phamacol. 14 (1962) 325-349
4. Alagarsamy V., Pathak U.S., Sriram D., Pandeya S.N., and De Clercq E. Indian J. Pharm. Sci. 62 (2000) 433
5. Misra P., Jain S., and Jain S. J. Indian Chem. Soc. 74 (1997) 816
6. Kung P.P., Casper M.D., Cook K.L., Lingardo L.W., Risen L.M., Vickers T.A., Ranken R., Blyn L.B., Wyatt J.R., Cook P.D., and Ecker D.J. J. Med. Chem. 42 (1999) 4705
7. Koizomi M., and Marakun Y. Jpn. Kokai 77 (1917) 51
8. Yakhontov L.N., Liberman S.S., Zhikhareva G.P., and Kuz'mina K.K. Khim.-Farm. Zh. 11 (1977) 14
9. Clinton R.O., Manson A.J., Stonner F.W., Beyler A.L., Potts G.O., and Arnold A. J. Am. Chem. Soc. 81 (1959) 1513
10. Miller T.C. J. Heterocycl. Chem. 3 (1966) 338-342
11. Clinton R.O., Manson A.J., Stonner F.W., Neumann H.C., Christiansen R.G., and Clarke R.L. J. Am. Chem. Soc. 83 (1961) 1478-1491
12. Clinton R.O., Manson A.J., Stonner F.W., Beyler A.L., Potts G.O., and Arnold A. J. Org. Chem. 26 1 (1961) 279
13. Ackerman J.H., Potts G.O., Beyler A.L., and Clinton R.O. J. Med. Chem. 7 2 (1964) 238-240
14. Chelucci G., Gladiali S., and Marchetti M.A. J. Heterocycl. Chem. 25 (1988) 1761-1765
15. Camoutsis C. J. Heterocycl. Chem. 33 (1996) 539-557
16. Green B., and Sheu K. Steroids 59 (1994) 479-480
17. Laitonjam W.S., Rajkumar T.S., and Chingakham B.S. Tetrahedron Lett. 44 (2003) 3071-3073
18. Hirschmann R., Buchschacher P., Steinberg N.G., Fried J.H., Ellis R., and Kent G.J. J. Am. Chem. Soc. 86 (1964) 1520-1527
19. Gupta R., Pathak D., and Jindal D.P. Eur. J. Med. Chem. 31 (1996) 241-247
20. Manson A.J., Stonner F.W., and Neumann H.C. J. Med. Chem. 6 (1963) 1-9
21. Wang S., Xie F., and Song K. Chem. Abstr. 119 (1993) 203669y
22. Hirschmann R., Steinberg N.G., Buchschacher P., Fried G.H., Kent G.J., and Tishler M. J. Am. Chem. Soc. 85 (1963) 120-122
23. Abid M., and Azam A. Bioorg. Med. Chem. Lett. 16 (2006) 2812-2816
24. Khan S.A., Saleem K., and Khan Z. Eur. J. Med. Chem. 42 (2007) 103-108
25. Wilkins D.T., Holdman V.L., Abramson J.I., and Moore E.W. Antimicrob. Agents Chemother. 1 (1972) 451
26. National Committee for Clinical, Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard, NCCLS Document M7-A4. fourth ed. (1997), National Committee for Clinical and Laboratory Standards, Villanova, PA
27. Zhang W., Berberoy M.E., Freeling J., He D., Moxley R.A., and Francis D.H. Infect. Immun. 74 (2006) 3107-3114
28. Fiesser L.F. J. Am. Chem. Soc. 75 (1953) 4395